Paper
Organic & Biomolecular Chemistry
n-nonane and n-tridecane as an internal standard. After fil- 2.12–2.04 (m, 2H), 1.79–1.71 (m, 2H), 1.64–1.56 (m, 1H),
+
tration, the reaction mixture was evaporated under vacuum 1.40–1.15 (m, 5H); ESIMS (positive) m/z 309 (M ). Spectral data
2
0
using an aspirator to give a solid residue which was recrystal- are in agreement with the literature.
lized from dichloromethane–hexane at −30 °C to give N-(cyclo- 4-Phenyl-[1,2,3]oxathiazinane-2,2-dioxide (15). (22.3 mg of 2
hexyl)trifluoromethanesulfonamide (3) (11.8 mg, 73%) as was used): White solids (2.7 mg, 24%); IR (KBr) 3280–3260,
colorless prisms; IR (KBr) 3350–3250 (br), 2933, 1454, 1373, 3067, 2967, 1418, 1357, 1186, 1015, 913, 781 cm− ; H NMR
1
1
−
1
1
3
221, 1066, 1007, 931, 613 cm ; δ 4.62 (br s, 1H), 3.58 (m, (400 MHz, CDCl ) δ 7.45–7.32 (m, 5H), 4.92–4.83 (m, 2H), 4.67
1
H), 2.07–1.97 (m, 2H), 1.80–1.70 (m, 2H), 1.67–1.57 (m, 1H), (ddd, J = 10.7, 4.3, 2.2 Hz, 1H), 4.26–4.18 (m, 1H), 2.31–2.18
+
1
.44–1.10 (m, 5H). Spectral data are in agreement with the (m, 1H), 2.07–2.00 (m, 1H); ESIMS m/z 236 [(M + Na) ]. Spectral
7
21
literature.
data are in agreement with the literature.
N-(Cyclopentyl)trifluoromethanesulfonamide (5). (32.2 mg
of 2 was used): A colorless oil; IR (neat) 3330–3270 (br), 2971,
−
1 1
1
446, 1375, 1232, 1192, 1146, 1022, 924, 609 cm ; H NMR
Acknowledgements
(400 MHz, CDCl ) δ 4.74 (br s, 1H), 3.97 (sext, J = 7.4 Hz, 1H),
3
2
.14–1.99 (m, 2H), 1.79–1.48 (m, 2H). Sulfonamide 5 shows a This work was supported by a Grant-in-Aid for Scientific
highly volatile nature which makes its isolation difficult. Thus, Research (B) (Japan Society for the Promotion of Science, JSPS)
1
5
was characterized by comparison of the H NMR and GCMS and a Grant-in-Aid for Young Scientist (B) (JSPS).
spectra with those of the authentic sample, prepared according
1
9
to a reported procedure.
N-(Cycloheptyl)trifluoromethanesulfonamide (6). (20.7 mg
of 2 was used): A colorless oil (6.3 mg, 51%); IR (neat)
Notes and references
3
6
330–3280 (br), 2932, 1435, 1377, 1230, 1192, 1147, 1039,
1 For a review, see: R. Samanta and A. P. Antonchick, Synlett,
2012, 809.
13 cm− ; H NMR (400 MHz, CDCl ) δ 4.79 (br s, 1H), 3.70
1
1
3
(
m, 1H), 2.11–1.97 (m, 2H), 1.69–1.40 (m, 10H). Spectral data
2 (a) Y. Yan, Y. Zhang, Z. Zha and Z. Wang, Org. Lett., 2013,
15, 2274; (b) Q. Xue, J. Xie, H. Li, Y. Cheng and C. Zhu,
Chem. Commun., 2013, 49, 3700; (c) Y. Takeda, J. Hayakawa,
K. Yano and S. Minakata, Chem. Lett., 2012, 41, 1672;
(d) M. Ochiai, S. Yamane, M. M. Hoque, M. Saito and
K. Miyamoto, Chem. Commun., 2012, 48, 5280.
7
are in agreement with the literature.
N-(Cyclooctyl)trifluoromethanesulfonamide (7). (24.8 mg of
2
was used): A colorless oil (9.8 mg, 63%); IR (neat) 3300–3270
br), 2925, 1435, 1378, 1230, 1194, 1149, 1054, 1018, 615 cm−
1
;
(
1
H NMR (400 MHz, CDCl ) δ 4.78 (br d, J = 8.6 Hz, 1H), 3.79
3
(
m, 1H), 2.00–1.90 (m, 2H), 1.75–1.44 (m, 12H). Spectral data
3 (a) M. Koag and S. Lee, Org. Lett., 2011, 13, 4766; (b) R. Fan,
W. Li, D. Pu and L. Zhang, Org. Lett., 2009, 11, 1425;
(c) R. Fan, D. Pu, F. Wen and J. Wu, J. Org. Chem., 2007, 72,
8994; (d) H. Togo, Y. Harada and M. Yokoyama, J. Org.
Chem., 2000, 65, 926; (e) H. Togo, Y. Hoshina, T. Muraki,
H. Nakayama and M. Yokoyama, J. Org. Chem., 1998, 63,
5193.
7
are in agreement with the literature.
N-(1,1,4-Trimethyl-1-pentyl)trifluoromethanesulfonamide (8).
(31.0 mg of 2 was used): A colorless oil (12.7 mg, 54%); IR
(neat) 3300–3290 (br), 2960, 1427, 1373, 1196, 1144, 1000,
27 cm− ; H NMR (400 MHz, CDCl ) δ 4.51 (br s, 1H), 1.78
1
1
6
3
(nonet, J = 6.6 Hz, 1H), 1.55 (d, J = 6.6 Hz, 2H), 1.43 (s, 6H),
0
.99 (d, J = 6.6 Hz, 6H). Spectral data are in agreement with the
4 A. A. Lamar and K. M. Nicholas, J. Org. Chem., 2010, 75,
7644.
7
literature.
N-(1-Ethyl-1-methyl-1-propyl)trifluoromethanesulfonamide
9). (17.9 mg of 2 was used): A colorless oil (6.5 mg, 64%); IR
5 H. Baba and H. Togo, Tetrahedron Lett., 2010, 51, 2063.
6 (a) D. S. Breslow, E. I. Edward, R. Leone and
P. v. R. Shleyer, J. Am. Chem. Soc., 1968, 90, 7097;
(b) N. Torimoto, T. Shingaki and T. Nagai, J. Org. Chem.,
1978, 43, 631; (c) P. Maslak, J. Am. Chem. Soc., 1989, 111,
8201.
(
(
1
1
neat) 3300–3280 (br), 2918, 1431, 1367, 1228, 1192, 1140,
014, 624 cm− ; H NMR (400 MHz, CDCl
1
1
) δ 4.45 (br s, 1H),
.66 (q, J = 7.0 Hz, 4H), 1.36 (s, 3H), 0.94 (t, J = 6.9 Hz, 6H).
3
Contaminated with a small amount of regioisomer. Spectral
7
data are in agreement with the literature.
7 M. Ochiai, K. Miyamoto, T. Kaneaki, S. Hayashi and
W. Nakanishi, Science, 2011, 332, 448.
N-(1,1-Dimethyl-1-propyl)trifluoromethanesulfonamide (10).
(
19.1 mg of 2 was used): A colorless oil (4.0 mg, 40%); IR (neat)
8 M. M. Hoque, K. Miyamoto, N. Tada, M. Shiro and
M. Ochiai, Org. Lett., 2011, 13, 5428.
9 For example, tosylamides readily undergo Hofmann type
rearrangement to give sulfamoyl fluoride, see: M. Ochiai,
T. Okada, N. Tada, A. Yoshimura, K. Miyamoto and
M. Shiro, J. Am. Chem. Soc., 2009, 131, 8392.
3
1
1
310–3290 (br), 2979, 1431, 1366, 1228, 1196, 1141, 1068,
003, 624 cm− ; H NMR (400 MHz, CDCl
1 1
) δ 4.54 (br s, 1H),
3
.67 (q, J = 7.1 Hz, 2H), 1.39 (s, 6H), 0.97 (t, J = 7.1 Hz, 3H).
7
Spectral data are in agreement with the literature.
N-(Cyclohexyl)-2,2,2-trichloroethoxysulfonamide
(12).
(
3
1
24.6 mg of 2 was used): White solids (3.4 mg, 18%); IR (KBr) 10 We could only detect N-(2,2,2-trichloroethoxysulfonyl)-
3
310–3290 (br), 2932, 2857, 1452, 1360, 1182, 1080, 1048,
imino-λ -bromane in the presence of cis-4-octene by low
−
1
1
1
022, 998, 933, 890, 855, 757 cm ; H NMR (400 MHz, CDCl
3
)
temperature H NMR measurement. See also Fig. S1 in
δ 4.62 (s, 2H), 4.45 (br d, J = 8.9 Hz, 1H), 3.49–3.39 (m, 1H),
ESI.†
Org. Biomol. Chem.
This journal is © The Royal Society of Chemistry 2014